PAV-220830FLY-618

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-618

4019-190702

NHP-220830FLY-2

anti-cd4 infusion premed. , Pre-dosing vitals; HR 120, RR 32, T 99.5. Interim vitals; HR 130, RR 36, T 99. End of infusion vitals; HR 140, RR 40, T 98.9. No adverse reaction. , anti-cd4 infusion premed

https://fairdomhub.org/sops/795

Blood; Treatment

Peripheral Blood Mononuclear Cells Freeze; Erythrocyte Sedimentation Rate; Complete Blood Count Blood Test

Flynn Lab

2019-07-02 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

435(42milliliter)

milligram

Diphenhydramine

Medication

Intramuscularly

8

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 9

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:36

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH